眉山地区肺动脉高压患者病因构成及住院转归研究

doi:10.12183/j.scjpm.2023.0018

摘要/Abstract

摘要： 目的探讨肺动脉高压患者病因构成并分析其住院转归情况。方法以2019年1月至2021年12月眉山地区3家医院收治的肺动脉高压患者为研究对象,根据患者病历资料及诊断结果,按照2008年Dana Point肺动脉高压分类法分析肺动脉高压患者病因构成;对患者特征及住院转归情况进行分析,并采用单、多因素分析方法对患者住院转归影响因素进行分析。结果共纳入1 748例肺动脉高压患者资料进行分析,动脉型肺动脉高压624例（35.70%）、左心疾病相关肺动脉高压811例（46.40%）、呼吸系统疾病或缺氧相关性肺动脉高压286例（16.36%）、慢性血栓性肺动脉高压23例（1.32%）、原因不明或多种因素所致肺动脉高压4例（0.23%）。性别、年龄及年份不同的肺动脉高压患者病因分布差异均有统计学意义（均P<0.01）。1 295例（74.08%）转归良好,453例（25.92%）转归不良（放弃治疗或死亡）。多因素Logistic回归分析结果显示,女性（OR=4.436）、年龄增长（OR=7.396）、病因为动脉型（OR=2.349）、左心疾病相关（OR=1.689）及呼吸系统疾病或缺氧相关（OR=1.379）、肺动脉高压分级升高（OR=1.499）、病程>60个月（OR=3.747）、有并发症（OR=2.149）、PaO₂异常（OR=2.654）以及PaCO₂异常（OR=1.319）是肺动脉高压患者住院转归不良的危险因素。结论肺动脉高压患者多发于41~50岁人群,其中女性多见,动脉型肺动脉高压和左心疾病相关肺动脉高压是肺动脉高压最常见病因。肺动脉高压患者转归不良发生率较高,且不同特征的患者住院转归存在明显差异。

关键词: 肺动脉高压, 病因构成, 住院转归, 因素分析

Abstract: Objective To investigate the etiological composition of patients with pulmonary arterial hypertension （PAH） and to analyze their hospitalization outcome. Methods PAH patients admitted to the 3 hospitals in Meishan area from January 2019 to December 2021 were enrolled in the study, and the etiological composition of PAH patients was analyzed according to the 2008 Dana Point Classification of PAH based on patient medical record data and diagnosis. The characteristics and hospitalization outcomes of the patients were analyzed, and the influencing factors of the hospitalization outcome were analyzed by univariate and multivariate analysis methods. Results A total of 1 748 PAH patients were included for analysis. There were 624 cases （35.70%） of arterial PAH, 811 cases （46.40%） of left heart disease-related PAH, 286 cases （16.36%） of respiratory diseases or hypoxia-related PAH, 23 cases （1.32%） of chronic thrombotic PAH, and 4 cases （0.23%） of PAH caused by unknown causes or multiple factors. There were statistically significant differences in the etiological distribution of PAH patients with different gender, ages, and years （all P < 0.01）. There were 1 295 cases （74.08%） of good outcomes and 453 cases （25.92%） of adverse outcomes （including the abandonment of treatment or death）. Multivariate Logistic regression analysis showed that the risk factors affecting the adverse outcomes of PAH patients were female （OR= 4.436）, age increase （OR= 7.396）, the disease was associated with the arterial type （OR= 2.349）, left heart disease （OR=1.689）, and respiratory system disease or hypoxia （OR=1.379）, the elevation of PAH grade （OR=1.499）, course of disease > 60 months （OR=3.747）, complications （OR=2.149）, abnormal PaO₂ （OR=2.654）, and abnormal PaCO₂（OR=1.319）. Conclusions PAH is most common in patients aged 41 to 50 years and is more common in women. Arterial PAH and left heart disease-related PAH are the most common causes of PAH. The incidence of adverse outcomes in PAH patients is high, and there are significant differences in hospitalization outcomes among patients with different characteristics.

Key words: Pulmonary arterial hypertension, Etiological composition, Hospitalization outcome, Factor analysis

中图分类号:

R195

黄静, 任松涛, 窦丽红, 陆光兵, 杨丹, 倪雪梅. 眉山地区肺动脉高压患者病因构成及住院转归研究[J]. 华南预防医学, 2023, 49(1): 18-22.

HUANG Jing, REN Song-tao, DOU Li-hong, LU Guang-bing, YANG Dan, NI Xue-mei. Etiological composition and hospitalization outcome of patients with pulmonary arterial hypertension in Meishan area[J]. South China Journal of Preventive Medicine, 2023, 49(1): 18-22.

参考文献

[1] Vazquez ZGS, Klinger JR.Guidelines for the treatment of pulmonary arterial hypertension[J]. Lung, 2020 ,198(4):581-596.
[2] Luna-López R, Ruiz Martín A, Escribano Subías P. Pulmonary arterial hypertension[J]. Med Clin (Barc),2022 ,158(12):622-629.
[3] Poch D, Mandel J. Pulmonary Hypertension[J]. Ann Intern Med, 2021 ,174(4):ITC49-ITC64.
[4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987.
[5] McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects[J]. Circulation, 2001 ,104(23):2797-2802.
[6] McGoon MD. The assessment of pulmonary hypertension[J]. Clin Chest Med,2001 ,22(3):493-508.
[7] 杨杏,叶瑞华,周丽芹.肺动脉高压患者的病因构成与肺动脉压力因素[J].华夏医学,2020,33(4):67-70.
[8] Bhatnagar A, Wiesen J, Dweik R, et al.Evaluating suspected pulmonary hypertension: A structured approach[J]. Cleve Clin J Med, 2018,85(6):468-480.
[9] Barragan-Martinez MD, Cueto-Robledo G, Roldan-Valadez E, et al. A brief review on gender differences in mexican-mestizo patients with pulmonary arterial hypertension (PAH) at a tertiary-level hospital[J]. Curr Probl Cardiol, 2022 ,47(9):101275.
[10] 李婧辰,张梅,李镒冲,等.我国40岁及以上人群慢性呼吸系统疾病症状流行现况及影响因素研究[J].中华流行病学杂志,2018,39(6):786-791.
[11] Cheron C, McBride SA, Antigny F, et al. Sex and gender in pulmonary arterial hypertension[J]. Eur Respir Rev,2021,30(162):200330.
[12] 张明娜,王秋月,侯刚,等.呼吸科肺动脉高压病因构成及肺动脉压力相关因素研究[J].中国实用内科杂志,2013,33(10):792-795.
[13] 赵智东,付会文,崔利锋,等.NT-proBNP与凝血功能、动脉血气分析对慢性肺心病急性加重期患者判断价值分析[J].中国实验诊断学,2020,24(12):1934-1938.
[14] 孙彦彦,卢甲,王卫平.心力衰竭合并肺动脉高压患者Gal-3、HMGB1及copeptin水平变化及临床意义[J].分子诊断与治疗杂志,2022,14(1):149-152.
[15] 张舒婷,姚青青,李宜珊,等.慢性低氧性肺动脉高压大鼠动脉血气分析指标的变化及其意义[J].实验动物与比较医学,2021,41(1):27-32,54.
[16] 赵艳菊,肖玉琴,王玲玲.动脉血气分析、凝血功能及肺动脉收缩压监测在慢性阻塞性肺疾病急性加重防治中的应用分析[J].实用医院临床杂志,2022,19(3):154-157.